We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » U.S., Eli Lilly Forge Deal for COVID-19 Antibody Drug
U.S., Eli Lilly Forge Deal for COVID-19 Antibody Drug
The U.S. government has struck a $375 million deal with Eli Lilly for 300,000 vials of its investigational COVID-19 treatment, LY-CoV555 (bamlanivimab).